Correlation Between RWE Aktiengesellscha and CRISPR Therapeutics

Can any of the company-specific risk be diversified away by investing in both RWE Aktiengesellscha and CRISPR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RWE Aktiengesellscha and CRISPR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between RWE Aktiengesellschaft and CRISPR Therapeutics AG, you can compare the effects of market volatilities on RWE Aktiengesellscha and CRISPR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RWE Aktiengesellscha with a short position of CRISPR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RWE Aktiengesellscha and CRISPR Therapeutics.

Diversification Opportunities for RWE Aktiengesellscha and CRISPR Therapeutics

0.0

Correlation Coefficient

RWE Aktiengesellscha  CRISPR Therapeutics

Pay attention - limited upside

The 3 months correlation between RWE and CRISPR is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding RWE Aktiengesellschaft and CRISPR Therapeutics AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CRISPR Therapeutics and RWE Aktiengesellscha is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RWE Aktiengesellschaft are associated (or correlated) with CRISPR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CRISPR Therapeutics has no effect on the direction of RWE Aktiengesellscha i.e., RWE Aktiengesellscha and CRISPR Therapeutics go up and down completely randomly.

Pair Corralation between RWE Aktiengesellscha and CRISPR Therapeutics

If you would invest  4,080  in CRISPR Therapeutics AG on October 25, 2024 and sell it today you would earn a total of  0.00  from holding CRISPR Therapeutics AG or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.33%
Values	Daily Returns

RWE Aktiengesellschaft  vs.  CRISPR Therapeutics AG

RWE Aktiengesellschaft

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days RWE Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

CRISPR Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days CRISPR Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, CRISPR Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with RWE Aktiengesellscha and CRISPR Therapeutics

The main advantage of trading using opposite RWE Aktiengesellscha and CRISPR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RWE Aktiengesellscha position performs unexpectedly, CRISPR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CRISPR Therapeutics will offset losses from the drop in CRISPR Therapeutics' long position.

The idea behind RWE Aktiengesellschaft and CRISPR Therapeutics AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..